Action Plan to enhance self-management and early detection of exacerbations in patients with COPD; a Randomized Controlled Trial

Completed

• Conditions: Chronic Bronchitis; Chronic lung disease; COPD; Emphysema; 10006436

• Registration Number: NL-OMON32089
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 180

Inclusion Criteria

- Diagnosis of COPD based on post-bronchodilatator FEV1 according to the GOLD
standards (=NHG standard).
- Diagnosis of COPD as the major functionally limiting disease.
- Current use of bronchodilator therapy.

Exclusion Criteria

- Primary diagnosis of asthma (onset < 35 years, >= 12 % postbronchodilator
reversibility in FEV1)
- Primary diagnosis of cardiac disease
- Primary diagnosis of other functionally limiting disease, that could significantly
affect either patient mortality (e.g. malignant neoplasm) or participation in the
study (e.g. confusional states, psychoses)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- (Clinical COPD Questionnaire) CCQ Symptom recovery time in the event of an<br /><br>exacerbation; number of 3 day CCQ units<br /><br>for the CCQ symptom score to have recovered from the exacerbation onset to<br /><br>the pre-exacerbation 3 unit average. </p><br>